Dr. Perelshteyn is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
1001 E Superior St
# L101
Duluth, MN 55802Phone+1 218-249-3081Fax+1 218-249-7875
Summary
- Dr. Anna Perelshteyn is a hematologist and medical oncologist and currently practices in Minnesota. Dr. Perelshteyn received her undergraduate degree from Columbia University, her medical degree from New York Medical College and completed her residency in SUNY Downstate and fellowship in Hematology and Medical Oncology in Northwell Health System in NY and has been in practice 13+ years. Dr. Perelshteyn specializes in breast cancer, gastrointestinal cancer, lung cancer and hematologic oncology. She also specializes in benign hematological disorders. Dr. Perelshteyn has multiple poster/abstracts publications and a journal publication with over 90 citings; and had done multiple teaching events and community outreach events.
Education & Training
- Zucker School of Medicine at Hofstra/NorthwellFellowship, Hematology and Medical Oncology, 2013 - 2016
- SUNY Downstate Health Sciences UniversityResidency, Internal Medicine, 2010 - 2013
- New York Medical CollegeClass of 2010
- Columbia University (Columbia College)BA, Biology, 2001 - 2005
Certifications & Licensure
- MN State Medical License 2016 - 2025
- NY State Medical License 2013 - 2020
- American Board of Internal Medicine Internal Medicine
- American Board of Internal Medicine Hematology
- American Board of Internal Medicine Medical Oncology
Publications & Presentations
PubMed
- 105 citationsA single-arm, nonrandomized phase II trial of neoadjuvant gemcitabine and oxaliplatin in patients with resectable pancreas adenocarcinoma.Eileen M. O'Reilly, Anna Perelshteyn, William R. Jarnagin, Mark A. Schattner, Hans Gerdes
Annals of Surgery. 2014-07-01
Abstracts/Posters
- Non-Transplantation-Related EBV-Positive Lymphoproliferative Disorder with Concurrent T-cell Angioimmunoblastic Lymphoma and B-cell Lymphoproliferative Disorder. Case ...Mahtahn, J. Perelshteyn, A., University of MN Duluth Research Symposium, Duluth, MN, 3/2023
- Prevalence of thyroid dysfunction as an effect of immune checkpoint inhibitor therapy.Demello J, Perelshteyn A., University of MN Duluth Research Symposium, Duluth, MN, 3/2023
- Development of a Lymphoproliferative Neoplasm during Treatment with Immunotherapy Checkpoint Inhibitor and CTLA-4 Inhibitor for Unrelated Solid tumor: A Case ReportSieling W, Perelshteyn A, University of MN Duluth Research Symposium, Duluth, MN, 4/2022
- Join now to see all
Press Mentions
- Lecture Subject: ‘Chemo Brain’June 12th, 2017
Professional Memberships
- Member
- Member
- Member
Other Languages
- Spanish, Russian
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: